Serum EMMPRIN/CD147 promotes the lung pre-metastatic niche in a D2A1 mammary carcinoma mouse model.

Feigelman G, Simanovich E, Rahat MA

Open source

DOI
10.3389/fimmu.2025.1568578
Published
2025
Container
Frontiers in immunology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2025.1568578,
  title = {Serum EMMPRIN/CD147 promotes the lung pre-metastatic niche in a D2A1 mammary carcinoma mouse model.},
  author = {Feigelman G and Simanovich E and Rahat MA},
  year = {2025},
  journal = {Frontiers in immunology},
  doi = {10.3389/fimmu.2025.1568578},
  url = {https://doi.org/10.3389/fimmu.2025.1568578}
}

RIS

TY  - JOUR
TI  - Serum EMMPRIN/CD147 promotes the lung pre-metastatic niche in a D2A1 mammary carcinoma mouse model.
AU  - Feigelman G
AU  - Simanovich E
AU  - Rahat MA
PY  - 2025
JO  - Frontiers in immunology
DO  - 10.3389/fimmu.2025.1568578
UR  - https://doi.org/10.3389/fimmu.2025.1568578
ER  - 

APA

G, F., E, S., & MA, R. (2025). Serum EMMPRIN/CD147 promotes the lung pre-metastatic niche in a D2A1 mammary carcinoma mouse model.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2025.1568578

Source records